Cargando…

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

The Cyfra 21.1 assay is a newly developed test which measures in serum a fragment of cytokeratin 19. We evaluated this marker in 212 patients with non-small-cell lung cancer (NSCLC), predominantly stage 3a-b and 4, and compared it with three other markers: carcinoembryonic antigen (CEA), squamous ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Gaast, A., Schoenmakers, C. H., Kok, T. C., Blijenberg, B. G., Cornillie, F., Splinter, T. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968860/ https://www.ncbi.nlm.nih.gov/pubmed/7510117

Ejemplares similares

Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
por: Giovanella, L., et al.
Publicado: (2017)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015)

Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
por: Matuszczak, Milena, et al.
Publicado: (2020)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
por: Cho, Hye-yon, et al.
Publicado: (2019)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer
por: Zhang, Yunxia, et al.
Publicado: (2020)

Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer
por: Ren, Hui, et al.
Publicado: (2019)

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease
por: Doweck, I, et al.
Publicado: (2000)

Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)

Long term survival of small cell lung cancer patients after chemotherapy.
por: van der Gaast, A., et al.
Publicado: (1993)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer
por: Zhao, Tongwei, et al.
Publicado: (2021)

Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma
por: Shiiya, Haruhiko, et al.
Publicado: (2021)

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
por: Barlési, F, et al.
Publicado: (2005)

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999)

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
por: Dal Bello, M. G., et al.
Publicado: (2019)

Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.
por: Splinter, T. A., et al.
Publicado: (1992)

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.
por: Kok, T. C., et al.
Publicado: (1996)

The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease
por: Kotowicz, Beata, et al.
Publicado: (2015)

Retracted: The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.
por: Tempfer, C., et al.
Publicado: (1998)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
por: Pujol, J-L, et al.
Publicado: (2004)

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
por: Nakata, B, et al.
Publicado: (2004)

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
por: Weber, Daniel Gilbert, et al.
Publicado: (2010)

AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors
por: Hao, Xiuxiu, et al.
Publicado: (2022)

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
por: Salama, G., et al.
Publicado: (1998)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
por: Kanaji, Nobuhiro, et al.
Publicado: (2019)

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021)

Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer.
por: van der Gaast, A., et al.
Publicado: (1991)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_4eeenkkdn3fd7sjtlnsmk3i6td